Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization

A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnancies

J. W. Meekins, Robert Pijnenborg, M. Hanssens et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1994 · 912 citations

Medicine, Gynecology, Obstetrics +15

Reproductive Technologies and the Risk of Birth Defects

Michael J. Davies, Vivienne Moore, Kristyn Willson et al. · New England Journal of Medicine · 2012 · 818 citations · Full text

Medicine, Maternal Health, Obstetrics +10

Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999)

M Bonduelle, I. Liebaers, V. Deketelaere et al. · Human Reproduction · 2002 · 534 citations · Full text

Public Health, Maternal Health, Obstetrics +17

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

Peter Humaidan, H.E. Bredkjær, Leif Bungum et al. · Human Reproduction · 2005 · 494 citations

Veterinary Medicine, Endocrinology, Gynecology +14

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

Lawrence Engmann, Andrea DiLuigi, David Schmidt et al. · Fertility and Sterility · 2007 · 430 citations

Medicine, Endocrinology, Gynecology +17